11 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
An introductory review of post-resection chemotherapeutics for primary brain tumors
Meaghan McGovern ... Brandon Lucke-Wold
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:537–544
Open Access
Review
Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
Qiuyue Zhang ... Mengsen Li
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:519–536
This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment
Open Access
Case Report
Spontaneous regression of a metastatic carcinoma transmitted by a kidney graft
Mikhail V. Kiselevskiy ... Irina Zh. Shubina
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:511–518
Open Access
Review
Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review
Raffaele Natella ... Antonella Santone
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:498–510
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Review
Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential
Eric Jou
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:474–497
This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment
Open Access
Perspective
Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
Ai Tsuji ... Satoru Matsuda
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:460–473
This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
Open Access
Original Article
Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors
Markus Schweipert ... Franz-Josef Meyer-Almes
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:447–459
Open Access
Original Article
Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers
Lisa T. Huber ... Cornelia Brunner
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:422–446
This article belongs to the special issue The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor
Open Access
Review
Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review
Giuseppe Di Costanzo ... Enrico Cavaglià
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:406–421
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Original Article
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy
Stijn Hentzen ... Anup Kasi
Published: June 29, 2023 Explor Target Antitumor Ther. 2023;4:396–405
Open Access
Review
Capitalizing glycomic changes for improved biomarker-based cancer diagnostics
Maria Luísa S. Silva
Published: June 28, 2023 Explor Target Antitumor Ther. 2023;4:366–395
This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
